BERNARDSVILLE, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Anima Biotech, the Tech.Bio leader bringing AI to mRNA biology, announced today positive preclinical data of its lung fibrosis candidate. This ...
Translational control is a relatively recent area of study in the pathways of diseases. The term refers to controlling a key mechanism in the body’s process of gene expression and protein synthesis ...
BERNARDSVILLE, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Anima Biotech, the leading Tech.Bio in the discovery of mRNA drugs and targets, today announced their participation in the upcoming 6 th Annual ...
BERNARDSVILLE, N.J., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Anima Biotech, the Tech.Bio leader in Visual Biology for drug discovery, will showcase its Lightning AI platform at the 3 rd annual ...
BERNARDSVILLE, N.J., March 21, 2023 (GLOBE NEWSWIRE) -- Anima Biotech, the leader in the discovery of small molecule mRNA drugs and their mechanisms of action by phenotypic screening with AI driven ...
BERNARDSVILLE, N.J., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Anima Biotech, the leading Tech.Bio in the discovery of mRNA drugs and targets, announced its third webinar, a part of their exclusive LightON ...
BERNARDSVILLE, N.J., Aug. 18, 2020 (GLOBE NEWSWIRE) -- Anima Biotech, the leader in the discovery of small molecule drugs that selectively control mRNA translation, today announced the company will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results